Cargando…
Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline
BACKGROUND: Strokes are becoming less severe due to increased numbers of intensive care units and improved treatments. As patients survive longer, post-stroke cognitive impairment (PSCI) has become a major health public issue. Diabetes has been identified as an independent predictive factor for PSCI...
Autores principales: | Cogo, Adrien, Mangin, Gabrielle, Maïer, Benjamin, Callebert, Jacques, Mazighi, Mikael, Chabriat, Hughes, Launay, Jean-Marie, Huberfeld, Gilles, Kubis, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885563/ https://www.ncbi.nlm.nih.gov/pubmed/33588894 http://dx.doi.org/10.1186/s13024-020-00421-4 |
Ejemplares similares
-
Intravenous Administration of Human Adipose Derived-Mesenchymal Stem Cells Is Not Efficient in Diabetic or Hypertensive Mice Subjected to Focal Cerebral Ischemia
por: Mangin, Gabrielle, et al.
Publicado: (2019) -
Perspectives on Quine /
Publicado: (1990) -
Quine in Spasms with Hooping Cough
por: Mayo, Thos. H.
Publicado: (1872) -
KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †
por: Lőrinczi, Bálint, et al.
Publicado: (2021) -
Despertando el ejército de terracota Quin == Awakened : Qin's terra-cotta army /
Publicado: (2001)